Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 052870/0473 | |
| Pages: | 6 |
| | Recorded: | 06/08/2020 | | |
| Attorney Dkt #: | 1065272.000469 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/15/2021
|
Application #:
|
15317069
|
Filing Dt:
|
12/07/2016
|
|
Publication #:
|
|
Pub Dt:
|
04/13/2017
| | | | |
|
Title:
|
COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND TUMOR VASCULATURE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/15/2021
|
Application #:
|
15317069
|
Filing Dt:
|
12/07/2016
|
|
Publication #:
|
|
Pub Dt:
|
04/13/2017
| | |
PCT #:
|
US2015034885
|
|
Title:
|
COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND TUMOR VASCULATURE
|
|
|
Assignee
|
|
|
|
|
| 4435 MAIN STREET |
| SUITE 500 |
| KANSAS CITY, MISSOURI 64111 |
|
|
Correspondence name and address
|
| |
BRYAN CAVE LEIGHTON PAISNER LLP
|
| |
1290 AVENUE OF THE AMERICAS
|
| |
NEW YORK, NY 10104
|
Search Results as of:
05/16/2024 03:43 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
